We are live on ! Find out more
MIRM icon

Mirum Pharmaceuticals
MIRM

104 hedge funds and large institutions have $650M invested in Mirum Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 47 increasing their positions, 25 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

206% more call options, than puts

Call options by funds: $422K | Put options by funds: $138K

88% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 25

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

3% less capital invested

Capital invested by funds: $673M → $650M (-$23.1M)

2.76% less ownership

Funds ownership: 93.18% → 90.42% (-2.8%)

7% less funds holding

Funds holding: 112 → 104 (-8)

30% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 23

Holders
104
Holders Change
-8
Holders Change %
-7.14%
% of All Funds
1.67%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.1%
New
16
Increased
47
Reduced
25
Closed
23
Calls
$422K
Puts
$138K
Net Calls
+$284K
Net Calls Change
-$80K

Top Buyers

1
EAM
Eventide Asset Management
Massachusetts
+$15.5M
2
State Street
State Street
Massachusetts
+$15.2M
3
TCM
Tang Capital Management
California
+$13.2M
4
Citadel Advisors
Citadel Advisors
Florida
+$9.55M
5
BlackRock
BlackRock
New York
+$7.66M

Top Sellers

1
Franklin Resources
Franklin Resources
California
-$22.4M
2
CCM
Cadian Capital Management
New York
-$19.5M
3
Victory Capital Management
Victory Capital Management
Texas
-$14.6M
4
FLAM
First Light Asset Management
Minnesota
-$11M
5
PCH
Polar Capital Holdings
United Kingdom
-$6.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$81.6M -$30.8K -1,558 -0%
FLSM
2
Frazier Life Sciences Management
California
$75.3M +$639K +32,326 +0.8%
BlackRock
3
BlackRock
New York
$41.7M +$7.66M +387,328 +22%
EAM
4
Eventide Asset Management
Massachusetts
$40.1M +$15.5M +782,000 +61%
DM
5
Deerfield Management
New York
$39.6M – – –
RSCM
6
Rock Springs Capital Management
Maryland
$35M – – –
State Street
7
State Street
Massachusetts
$34.3M +$15.2M +769,656 +78%
NHAS
8
Novo Holdings A/S
Denmark
$32.8M – – –
RVM
9
RiverVest Venture Management
Missouri
$31.6M -$5.93M -300,000 -16%
Citadel Advisors
10
Citadel Advisors
Florida
$27.5M +$9.55M +483,382 +52%
Vanguard Group
11
Vanguard Group
Pennsylvania
$24.6M +$343K +17,373 +1%
TCM
12
Tang Capital Management
California
$21.8M +$13.2M +670,000 +149%
Axa
13
Axa
France
$18.5M +$1.75M +88,327 +10%
PCH
14
Polar Capital Holdings
United Kingdom
$16.7M -$6.42M -325,000 -28%
Goldman Sachs
15
Goldman Sachs
New York
$8.61M +$4.07M +205,747 +87%
Franklin Resources
16
Franklin Resources
California
$7.81M -$22.4M -1,135,642 -74%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$7.79M +$399K +20,180 +5%
Barclays
18
Barclays
United Kingdom
$7.36M +$5.71M +288,695 +325%
CCM
19
Cadian Capital Management
New York
$7.36M -$19.5M -987,412 -72%
WP
20
Woodline Partners
California
$7.03M +$72K +3,640 +1%
Point72 Asset Management
21
Point72 Asset Management
Connecticut
$6.62M +$6.71M +339,510 New
PM
22
Prosight Management
Texas
$6.02M +$470K +23,776 +8%
Ensign Peak Advisors
23
Ensign Peak Advisors
Utah
$4.4M -$104K -5,250 -2%
Northern Trust
24
Northern Trust
Illinois
$4.15M +$89.4K +4,523 +2%
SAM
25
Silvercrest Asset Management
New York
$3.93M +$817K +41,343 +26%
1
2 3 4 5

MIRM Hedge Fund Activity: Q4 2022 in Review

104 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q4 2022, worth a combined $650M — down 3.4% from $673M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of MIRM and 16 opened new positions — a net loss of 7 holders — while 25 trimmed existing stakes and 47 added.

The largest buyer was Eventide Asset Management, adding an estimated $15.5M. The largest seller was Franklin Resources, cutting an estimated $22.4M.

  • 104 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q4 2022, down from 112 in Q3 2022.
  • Funds reported $650M of Mirum Pharmaceuticals stock for Q4 2022, down 3.4% quarter-over-quarter.
  • 16 funds opened new Mirum Pharmaceuticals positions in Q4 2022 and 23 closed out, a net change of -7 holders.
  • The largest Mirum Pharmaceuticals buyer in Q4 2022 was Eventide Asset Management, an estimated $15.5M added.
  • The largest Mirum Pharmaceuticals seller in Q4 2022 was Franklin Resources, an estimated $22.4M sold.

Based on aggregated 13F filings for Q4 2022.